Shift Bioscience, a biotech company using an AI powered virtual cell to fight age-related diseases, today announced the establishment of a new North American team and facilities to advance development ...
The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...
A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...
GloboCare has received a Notice of Allowance from the China National Intellectual Property Administration for its patent ...
Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
A revolutionary approach to immune therapy has emerged: engineered immune cells that protect healthy tissue without ...
Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...
In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than ...
Though the baseline illness severity was uneven, with more severe patients in the itolizumab arm, the medication showed great ...
Collaboration to explore the immunoregulation of NK and T cells within the tumor microenvironment (TME) by CAPTN-3, with the goal of enhancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback